Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vergani

Showing results (61-70 of 249) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|December 7, 1991
Glutamic acid decarboxylase expression in islets and brainR Giorda, M Peakman, K C Tan, et al.
British Journal of Anaesthesia|November 1, 1981
Hepatic damage after exposure to halothane in medical personnelJ Neuberger, D Vergani, G Mieli-Vergani, et al.
Journal of Immunological Methods|September 25, 1995
Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvementJ Ochola, M Hussain, M Khamashta, et al.
Diabetes Care|November 1, 1996
Persistent activation of CD8+ T-cells characterizes prediabetic twinsM Peakman, R D Leslie, L Alviggi, et al.
Clinical and Experimental Immunology|December 1, 1995
Cell cycling in HIV infection: analysis of in vivo activated lymphocytesM Mahalingam, A Pozniak, T J McManus, et al.
Lancet (London, England)|October 14, 1978
Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesiaD Vergani, D Tsantoulas, A L Eddleston, et al.
Archives of Disease in Childhood|December 1, 1988
IgG subclass deficiency in asthmaB G Loftus, J F Price, A Lobo-Yeo, et al.
Bone Marrow Transplantation|September 27, 2006
Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host diseaseC G Mullighan, D-P Bogdanos, D Vergani, et al.
Archives of Disease in Childhood|July 1, 1992
Complement activation in neonatal infectionM Peakman, G Senaldi, G Liossis, et al.
Gut|June 1, 1990
Soluble interleukin 2 receptors in autoimmune chronic active hepatitisA Lobo-Yeo, G Mieli-Vergani, A P Mowat, et al.
Pageof 25

Showing results (61-70 of 249) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|December 7, 1991
Glutamic acid decarboxylase expression in islets and brainR Giorda, M Peakman, K C Tan, et al.
British Journal of Anaesthesia|November 1, 1981
Hepatic damage after exposure to halothane in medical personnelJ Neuberger, D Vergani, G Mieli-Vergani, et al.
Journal of Immunological Methods|September 25, 1995
Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvementJ Ochola, M Hussain, M Khamashta, et al.
Diabetes Care|November 1, 1996
Persistent activation of CD8+ T-cells characterizes prediabetic twinsM Peakman, R D Leslie, L Alviggi, et al.
Clinical and Experimental Immunology|December 1, 1995
Cell cycling in HIV infection: analysis of in vivo activated lymphocytesM Mahalingam, A Pozniak, T J McManus, et al.
Lancet (London, England)|October 14, 1978
Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesiaD Vergani, D Tsantoulas, A L Eddleston, et al.
Archives of Disease in Childhood|December 1, 1988
IgG subclass deficiency in asthmaB G Loftus, J F Price, A Lobo-Yeo, et al.
Bone Marrow Transplantation|September 27, 2006
Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host diseaseC G Mullighan, D-P Bogdanos, D Vergani, et al.
Archives of Disease in Childhood|July 1, 1992
Complement activation in neonatal infectionM Peakman, G Senaldi, G Liossis, et al.
Gut|June 1, 1990
Soluble interleukin 2 receptors in autoimmune chronic active hepatitisA Lobo-Yeo, G Mieli-Vergani, A P Mowat, et al.
Pageof 25